Success Story: NIW Victory under Premium Processing! An Applied AI Researcher Achieves Success
Client’s Testimonial:
"I am very satisfied with my attorney's professionalism and support throughout my case. They were responsive, detail-oriented, and made the entire process clear and smooth."
On May 18th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for an Expert in the Field of Applied AI (Approval Notice).
General Field: Applied AI
Country of Origin: Bangladesh
State of Residence at the Time of Filing: New York
Approval Notice Date: May 18th, 2026
Processing Time: 1 month, 9 days (Premium Processing Requested)
Case Summary:
This approval reflects our firm's dedication to crafting well-supported, strategically compelling petitions for high-achieving researchers worldwide. We are pleased to share the success of an EB-2 NIW (National Interest Waiver) petition for a researcher in applied AI from Bangladesh. Holding an M.Sc. in information technology, this researcher secured approval by demonstrating that their work carries both substantial merit and national importance to the United States.
Our firm successfully argued that contributions to safe, transparent, and human-centered clinical AI systems, spanning clinical decision support, early health risk detection, and predictive monitoring for vulnerable populations, directly support critical national priorities in patient safety, public health infrastructure, and U.S. technological leadership in artificial intelligence.
Research Focus and National Importance
The proposed endeavor focuses on developing safe, transparent, and human-centered clinical AI systems to improve clinical decision-making, enable early detection of health risks, and strengthen patient safety and public health infrastructure in the United States.
This work holds clear national importance. Patient safety and chronic disease management remain pressing challenges in the U.S. healthcare system, and AI has been widely recognized as a critical tool for addressing them. By advancing the trustworthiness and reliability of clinical AI, this research directly supports federal priorities in healthcare innovation. It aligns with national initiatives identifying AI and machine learning as critical and emerging technologies vital to U.S. leadership, national security, and long-term competitiveness.
Demonstrating Influence Through Research Impact
To demonstrate that this researcher is well-positioned to advance the proposed endeavor, our firm presented a strong and documented record of scholarly achievement. The portfolio includes 10 peer-reviewed journal articles (2 of them first-authored), 1 first-authored book, and 1 first-authored granted patent. The work has been cited 72 times.
Beyond publications, this researcher has been regularly invited to conduct peer reviews for leading journals in the field and has completed at least 2 reviews to date. The client also serves on the editorial board of a peer-reviewed journal in health informatics, further reflecting the scientific community's recognition of this researcher as a trusted expert in applied AI.
The Result
With our firm's strategic preparation and careful framing of the petition, approval was granted in over 1 month under premium processing without an RFE. This outcome reflects both the strength of the contributions presented and our team's expertise in showcasing complex scientific work in the most compelling light. We are proud to have supported this dedicated researcher and extend our sincere best wishes for continued success in advancing responsible AI for healthcare and improving patient outcomes across the United States.